Tag: Medical Equipment and Devices

Displaying 1 - 11 of 11 results.

Filtering by content type: Press Release

At the Federal Trade Commission’s request, a U.S. district court has temporarily shut down a Brooklyn, New York-based operation that the allegedly used deception, threats, and intimidation to induce elderly consumers to pay for medical alert systems they neither ordered nor wanted.
Following a public comment period, the Federal Trade Commission has approved a final settlement order in the matter of Danaher Corporation and MDS, Inc., and sent a letter to the one member of the public who commented on it. The final order settles charges that Danaher’s acquisition of MDS, as...
The Federal Trade Commission announced today that it will require the divestiture of MDS Inc.’s assets related to its laser microdissection business as a condition of allowing Danaher Corporation and MDS Analytical Technologies (US) Inc. to proceed with their proposed merger. The proposed...
Following the Federal Trade Commission’s approval of a lawsuit to block the transaction, Thoratec Corporation today announced that it has abandoned its proposed $282 million acquisition of HeartWare International. The FTC’s complaint charged that the deal would be illegal because it would...
The Federal Trade Commission has authorized a lawsuit to block Thoratec Corporation’s proposed $282 million acquisition of rival medical device maker HeartWare International, Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices...
Getinge AB has settled Federal Trade Commission charges that its proposed $865 million acquisition of rival Datascope Corporation would be anticompetitive and would violate federal antitrust laws. Under the settlement with the Commission, Datascope is required to divest its endoscopic vessel...
Commission issuance of information requests: The Commission has issued information requests to generic and authorized generic drug manufacturers and marketers as part of its ongoing study of the short- and long-term effects of authorized generics on pharmaceutical drug competition. The current set...
The Federal Trade Commission today announced a complaint challenging Kyphon, Inc.’s (Kyphon) proposed acquisition of the spinal assets of Disc-O-Tech Medical Technologies, Ltd. and Discotech Orthopedic Technologies, Inc. (collectively Disc-O-Tech) as anticompetitive in the U.S. market for...
The Federal Trade Commission today charged that Thermo Electron Corporation’s proposed $12.8 billion acquisition of Fisher Scientific International, Inc. would harm competition in the U.S. market for high-performance centrifugal vacuum evaporators (CVEs) in violation of the antitrust laws.
United States Attorney Michael J. Sullivan, Assistant Attorney General Robert D. McCallum, Jr., and Federal Trade Commission Bureau of Competition Director Joe Simons announced today that a federal judge has fined Boston Scientific Corporation (BSC) more than $7 million for violating an FTC order...
Citing several violations of a 1995 Federal Trade Commission consent order, the U.S. Department of Justice (DOJ) has filed a complaint against Boston Scientific Corporation (BSC), on behalf of the Commission, seeking civil penalties and other equitable relief. According to the complaint, BSC...